Editorial: Global excellence in inflammatory diseases: North America 2021

por Kusner, Linda L., Misra, Ravi S., Lucas, Rudolf
Publicado 2023

Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment

por Sengupta, Manjistha, Cheema, Amrita, Kaminski, Henry J., Kusner, Linda L.
Publicado 2014

Targeting Therapy to The Neuromuscular Junction: Proof of Concept

por Kusner, Linda L, Satija, Namita, Cheng, Georgiana, Kaminski, Henry J
Publicado 2014

Survivin as a Potential Mediator to Support Autoreactive Cell Survival in Myasthenia Gravis: A Human and Animal Model Study

por Kusner, Linda L., Ciesielski, Michael J., Marx, Alexander, Kaminski, Henry J., Fenstermaker, Robert A.
Publicado 2014

Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats

por Kaminski, Henry J., Himuro, Keiichi, Alshaikh, Jumana, Gong, Bendi, Cheng, Georgiana, Kusner, Linda L.
Publicado 2016

MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis

por Sengupta, Manjistha, Wang, Bi-Dar, Lee, Norman H., Marx, Alexander, Kusner, Linda L., Kaminski, Henry J.
Publicado 2018

Serum metabolomics of treatment response in myasthenia gravis

por Sikorski, Patricia, Li, Yaoxiang, Cheema, Mehar, Wolfe, Gil I., Kusner, Linda L., Aban, Inmaculada, Kaminski, Henry J.
Publicado 2023

The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis

por Xie, Yanchen, Li, Hai-Feng, Sun, Liang, Kusner, Linda L., Wang, Shuhui, Meng, Yunxiao, Zhang, Xu, Hong, Yu, Gao, Xiang, Li, Yao, Kaminski, Henry J.
Publicado 2017

Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis

por Kusner, Linda L., Yucius, Kristina, Sengupta, Manjistha, Sprague, Andrew G., Desai, Dhruv, Nguyen, Tuyen, Charisse, Klaus, Kuchimanchi, Satya, Kallanthottathil, Rajeev, Fitzgerald, Kevin, Kaminski, Henry J., Borodovsky, Anna
Publicado 2019